Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chi

Showing results (381-390 of 410) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2021
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUPMartin R Stockler, Andrew J Martin, Ian D Davis, et al.
Nature Communications|February 28, 2024
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancerNicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Cancer Discovery|July 2, 2026
Germline CDK12 variants in aggressive prostate cancerSofie H Tolmeijer, Corinne Maurice-Dror, Shahneen Sandhu, et al.
JAMA Network Open|October 28, 2020
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene AberrationsSabine Schmid, Aurelius Omlin, Celestia Higano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
Neuro-Oncology|January 21, 2017
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumorsShakti H Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, et al.
Nature Cancer|May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactionsAlexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.
Lancet (London, England)|September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Nature Cancer|July 5, 2022
Structural variants shape driver combinations and outcomes in pediatric high-grade gliomaFrank P B Dubois, Ofer Shapira, Noah F Greenwald, et al.
Pageof 41

Showing results (381-390 of 410) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2021
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUPMartin R Stockler, Andrew J Martin, Ian D Davis, et al.
Nature Communications|February 28, 2024
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancerNicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, et al.
Nature Communications|July 11, 2024
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancerSuzanne J Forrest, Hersh Gupta, Abigail Ward, et al.
Cancer Discovery|July 2, 2026
Germline CDK12 variants in aggressive prostate cancerSofie H Tolmeijer, Corinne Maurice-Dror, Shahneen Sandhu, et al.
JAMA Network Open|October 28, 2020
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene AberrationsSabine Schmid, Aurelius Omlin, Celestia Higano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
Neuro-Oncology|January 21, 2017
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumorsShakti H Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, et al.
Nature Cancer|May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactionsAlexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.
Lancet (London, England)|September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Nature Cancer|July 5, 2022
Structural variants shape driver combinations and outcomes in pediatric high-grade gliomaFrank P B Dubois, Ofer Shapira, Noah F Greenwald, et al.
Pageof 41